🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Cancer, Adult

Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer NCT07529626n/a3 sites📍 Changsha📍 Shanghai📍 Xi’an Shanghai Zhongshan Hospital KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites📍 Phoenix📍 Tucson📍 Los Angeles Kura Oncology, Inc. · Tests: Darlifarnib, Cabozantinib, Adagrasib A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer NCT05365581Phase 146 sites📍 Orange📍 Santa Monica📍 Chicago Astellas Pharma Global Development, Inc. · Tests: ASP2138, Pembrolizumab, Oxaliplatin, Leucovorin, Fluorouracil Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites📍 Darlinghurst📍 Randwick📍 Westmead Myeloid Therapeutics · Tests: MT-302 (A) A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites📍 Phoenix📍 Scottsdale📍 Duarte Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue NCT06989437Phase 2, Phase 3230 sites📍 Birmingham📍 Birmingham📍 Phoenix Pfizer · Tests: ponsegromab, placebo IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation NCT06778863Phase 121 sites📍 Scottsdale📍 Tucson📍 Los Angeles Clasp Therapeutics, Inc. · Tests: CLSP-1025 A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Miami Astellas Pharma Global Development, Inc. · Tests: ASP546C To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC NCT07591571NA1 site📍 Loma Linda Loma Linda University · Tests: PAL-CHW-PDAC, Usual Care with Attention Control Resilience and Equity in Aging, Cancer, and Health (REACH) NCT04674267NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Phase 2 Intervention - Geriatric Co-Management Prehab for Pancreatic Cancer Surgery NCT07478185NA1 site📍 Worester University of Massachusetts, Worcester · Tests: Multimodal Prehabilitation Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors NCT07523529Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous dual-target CAR-T cells selected from the predefined target library., Fludarabine, Cyclophosphamide Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer NCT06800469NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Microbiota analysis SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites📍 Glen Burnie📍 Pittsburgh📍 Seoul SK Life Science, Inc. · Tests: SKL35501, SKL35502 Adebrelimab and Chidamide for Pancreatic Cancer NCT06584227Phase 21 site📍 Nanjing Liu Xiufeng · Tests: Adebrelimab and Chidamide Combined with Gemcitabine and S1 A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors NCT07094204Phase 120 sites📍 Santa Monica📍 Atlanta📍 Jefferson Astellas Pharma Inc · Tests: ASP5834, panitumumab InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers NCT05779917Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: CAR-T cells A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations NCT06835569Phase 114 sites📍 Orlando📍 Tampa📍 Boston Alterome Therapeutics, Inc. · Tests: ALTA3263, cetuximab, mFOLFOX6, Pembrolizumab, Pemetrexed + Cisplatin /Carboplatin A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations NCT07629960Phase 1, Phase 216 sites📍 Sarasota📍 Tampa📍 Baton Rouge Blueprint Medicines Corporation · Tests: BLU-924 A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer NCT07227168Phase 19 sites📍 San Diego📍 Denver📍 Washington D.C. Sutro Biopharma, Inc. · Tests: STRO-004, Pembrolizumab A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors NCT06598007Phase 1, Phase 21 site📍 Houston Crossignal Therapeutics, Inc. · Tests: CT3001, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling NCT06717295n/a4 sites📍 Rosario📍 Lagos📍 Cambridge Javier Toledo · Tests: DiNanoQ: A multi-cancer early detection (MCED) blood test, DiNanoTrack: Therapeutic Response Monitoring Blood Test Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer NCT07436741Phase 31 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: surufatinib + gemcitabine + nab-paclitaxel, gemcitabine + nab-paclitaxel Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing NCT04981119n/a16 sites📍 Gilbert📍 Phoenix📍 Duarte A2 Biotherapeutics Inc. · Tests: Apheresis, Next Generation Sequencing (NGS), Long Range NGS HLA typing Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase NCT04195347Phase 1, Phase 23 sites📍 Charlotte📍 Cincinnati📍 Memphis St. Jude Children's Research Hospital · Tests: CM4620 Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis NCT06822413n/a4 sites📍 Nanchang📍 Nanchang📍 Shanghai Second Affiliated Hospital, Zhejiang University, School of … · Tests: No Interventions Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study) NCT05431270Phase 1, Phase 26 sites📍 Huntersville📍 Oklahoma City📍 Nashville Phanes Therapeutics · Tests: Mavrostobart (PT199), Tislelizumab, Gemcitabine + nab-Paclitaxel, Docetaxel, Pemetrexed DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy